Stellar Biotechnologies Company Profile (NASDAQ:SBOT)

Analyst Ratings

Consensus Ratings for Stellar Biotechnologies (NASDAQ:SBOT) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.00 (426.33% upside)

Analysts' Ratings History for Stellar Biotechnologies (NASDAQ:SBOT)
Show:
DateFirmActionRatingPrice TargetActions
5/12/2016Maxim GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Stellar Biotechnologies (NASDAQ:SBOT)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Stellar Biotechnologies (NASDAQ:SBOT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.17)($0.17)($0.17)
Q2 20161($0.18)($0.18)($0.18)
Q3 20161($0.19)($0.19)($0.19)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Stellar Biotechnologies (NASDAQ:SBOT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Stellar Biotechnologies (NASDAQ:SBOT)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Stellar Biotechnologies (NASDAQ:SBOT)
DateHeadline
07/23/16 10:05 AMStellar Biotechnologies Incorporated (NASDAQ:SBOT) Shorted Shares Increased 366.67% After Market Selling - Consumer Eagle
07/23/16 10:05 AMShares Stumbling of Late: Stellar Biotechnologies, Inc. (:SBOT) - TGP
07/21/16 06:37 PMStellar Biotechnologies Inc Stock Technicals Hit Weakness - CML News
07/19/16 06:26 PMNeovacs S A , FR0004032746
07/19/16 06:26 PMDGAP-News: Neovacs and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture to Manufacture Kinoids
07/19/16 07:24 AMNeovacs and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture to Manufacture Kinoids - PharmiWeb.com (press release)
07/19/16 07:24 AMBig Movers: JA Solar Holdings Co., Ltd. (NASDAQ:JASO), Stellar Biotechnologies, Inc. (NASDAQ:SBOT), Tenet ... - KC Register
07/19/16 07:24 AMInvestor Watch: Volatility Recap on Shares of: Stellar Biotechnologies, Inc. (:SBOT) - Engelwood Daily
07/19/16 07:00 AMStellar Biotechnologies and Neovacs Announce Formation of New Company Neostell S.A.S. in France - [Marketwired] - Stellar Biotechnologies, Inc. and Neovacs S.A. today announced the formation of Neostell S.A.S. , a simplified stock corporation headquartered in France, to carry out the business of the companies' joint ...
07/19/16 01:15 AMNeovacs and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture to Manufacture Kinoids - [GlobeNewswire] - PARIS, BOSTON, and PORT HUENEME, Calif., July 19, 2016-- NEOVACS and STELLAR BIOTECHNOLOGIES Inc. today announced the start of their joint venture company, Neostell SAS, with the holding of its first general ...
07/15/16 05:17 PMIncreased Volatility Noted on Shares of: Stellar Biotechnologies, Inc. (:SBOT) - Engelwood Daily
07/15/16 05:17 PMStellar Biotechnologies Inc (NASDAQ:SBOT)'s Company Shares Increased 20.83% After Low Volatility - Consumer Eagle
07/14/16 09:54 AMTop Wall Street Stories: Gold Resource Corp (NYSEMKT:GORO), Stellar Biotechnologies, Inc. (NASDAQ:SBOT ... - KC Register
07/12/16 06:33 PMStellar Biotechnologies Incorporated (NASDAQ:SBOT) Short Interest Decreased By 10.61% - Consumer Eagle
07/07/16 06:23 PMStock Moving Up in Trading: Stellar Biotechnologies, Inc. (:SBOT) - Telanagana Press
07/07/16 05:02 AMSTELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events -
07/06/16 06:38 PMStellar Biotechnologies Announces Closing of Registered Direct Offering - Yahoo Finance
07/04/16 10:53 AMCompany Stock Lower on the Week Stellar Biotechnologies, Inc. (:SBOT) - Engelwood Daily
07/02/16 08:56 AMStock Update (NASDAQ:SBOT): Stellar Biotechnologies Inc Announces Pricing of $6.75 Million Registered Direct Offering - Smarter Analyst
06/30/16 11:42 AMHere’s Why Traders Are Buzzing Around Lions Gate, Stellar Biotechnologies, and Three Other Stocks -
06/30/16 09:04 AMStellar Biotechnologies Announces Pricing of $6.75 Million Registered Direct Offering
06/30/16 08:23 AMSTELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq -
06/28/16 06:12 PMCheck on Share Volatility: Stellar Biotechnologies, Inc. (:SBOT) - Engelwood Daily
06/28/16 06:12 PMShares Reaching Overbought Territory: Stellar Biotechnologies, Inc. (:SBOT) - Press Telegraph
06/28/16 11:04 AMStock Volatility in Review: Stellar Biotechnologies, Inc. (:SBOT) - Engelwood Daily
06/28/16 11:04 AMChecking on Unusual Volume for: Stellar Biotechnologies, Inc. (:SBOT) - Engelwood Daily
06/26/16 10:41 AMStellar Bio bucks the market, shares up 20% - Seeking Alpha
06/26/16 10:41 AMTyco International plc (NYSE:TYC) Went Up 1.15%: Stellar Biotechnologies, Inc. (NASDAQ:SBOT), Anika Therapeutics ... - KC Register
06/26/16 10:41 AMShare Volatility Check for: Stellar Biotechnologies, Inc. (:SBOT) - Press Telegraph
06/24/16 08:52 AMStellar Biotechnologies: Vaccine Tech Buoyed By Partnerships - Seeking Alpha
06/23/16 08:00 AMMaxim's Jason McCarthy Interviewed by The Life Sciences Report - [Marketwired] - Maxim Analyst Jason McCarthy sees nothing but blue sky for Stellar Biotechnologies Inc., even though its product originated in the deep blue sea. With blockbuster indications like cancer, lupus and Alzheimer's ...
06/04/16 09:15 AMStellar Biotechnologies Incorporated (NASDAQ:SBOT) Short Interest Decreased By 2.91% - HNN
06/02/16 06:46 PMStellar Biotechnologies to Present at LD Micro Invitational Conference - Marketwired (press release) - Stellar Biotechnologies to Present at LD Micro Invitational ConferenceMarketwired (press release)PORT HUENEME, CA--(Marketwired - Jun 2, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") ( NASDAQ : SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), today announced that the Company will present ...and more »
06/02/16 09:21 AMStellar Biotechnologies to Present at LD Micro Invitational Conference - Digital Journal - Stellar Biotechnologies to Present at LD Micro Invitational ConferenceDigital JournalPORT HUENEME, CA--(Marketwired - Jun 2, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") ( NASDAQ : SBOT ), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), today announced that the Company will present ...and more »
06/02/16 07:05 AMStellar Biotechnologies to Present at LD Micro Invitational Conference - [at noodls] - PORT HUENEME, CA -- (Marketwired) -- 06/02/16 -- Stellar Biotechnologies, Inc. ('Stellar' or 'the Company') (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ('KLH'), today ...
05/25/16 09:45 AMStellar Biotechnologies Named as a 2016 California Small Business of the Year - Marketwired (press release) - Stellar Biotechnologies Named as a 2016 California Small Business of the YearMarketwired (press release)PORT HUENEME, CA--(Marketwired - May 25, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "Company") ( NASDAQ : SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), announced that the Company will be recognized ...and more »
05/25/16 08:16 AMStellar Biotechnologies Named as a 2016 California Small Business of the Year - [at noodls] - PORT HUENEME, CA -- (Marketwired) -- 05/25/16 -- Stellar Biotechnologies, Inc. ('Stellar' or 'Company') (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ('KLH'), announced ...
05/23/16 09:51 AMStellar Biotechnologies Appoints Michael L. Klein, Ph.D. as Vice President of Chemistry, Manufacturing and Controls ... - Marketwired (press release) - Stellar Biotechnologies Appoints Michael L. Klein, Ph.D. as Vice President of Chemistry, Manufacturing and Controls ...Marketwired (press release)PORT HUENEME, CA--(Marketwired - May 23, 2016) - Stellar Biotechnologies, Inc. ("Stellar" or "Company") ( NASDAQ : SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ("KLH"), today announced the appointment of Michael L.and more »
05/23/16 09:51 AMInvestors Alert: Stellar Biotechnologies, Inc. (NASDAQ:SBOT), Kitov Pharmaceuticals Holdings LTD (NASDAQ:KTOV ... - KC Register - Investors Alert: Stellar Biotechnologies, Inc. (NASDAQ:SBOT), Kitov Pharmaceuticals Holdings LTD (NASDAQ:KTOV ...KC RegisterOn 9 May, Stellar Biotechnologies, Inc. (NASDAQ:SBOT) reported Total expenses were $1.42 million and $3.22 million for the second quarter and six months ended March 31, 2016, compared to $1.38 million and $2.92 million for the same periods in 2015.and more »
05/23/16 07:46 AMStellar Biotechnologies Appoints Michael L. Klein, Ph.D. as Vice President of Chemistry, Manufacturing and Controls (CMC) - [at noodls] - PORT HUENEME, CA -- (Marketwired) -- 05/23/16 -- Stellar Biotechnologies, Inc. ('Stellar' or 'Company') (NASDAQ: SBOT), the leader in sustainable manufacture of Keyhole Limpet Hemocyanin ('KLH'), today ...
05/20/16 09:52 AMAnalysts Offer Insights on Healthcare Companies: Check-Cap Ltd. (NASDAQ: CHEK) and Stellar Biotechnologies Inc ... - Analyst Ratings - Analysts Offer Insights on Healthcare Companies: Check-Cap Ltd. (NASDAQ: CHEK) and Stellar Biotechnologies Inc ...Analyst RatingsThere's a lot to be optimistic about in the Healthcare sector as 2 experts just weighed in on Check-Cap Ltd. (NASDAQ: CHEK) and Stellar Biotechnologies Inc (NASDAQ: SBOT) with bullish sentimens. Check-Cap Ltd. (NASDAQ: CHEK). In a report released ...
05/19/16 10:00 AMMorning Stocks Movement: Big Gainers - TISA, CLWT, CETX, PULM, SMT, RXII, RPRX - FxPips.com - Morning Stocks Movement: Big Gainers - TISA, CLWT, CETX, PULM, SMT, RXII, RPRXFxPips.comVenaxis Inc (APPY) traded at $3.90 + 0.31 (8.64 pct) on 74,865 total stock volume. The company is +60.10 pct year-to-date, and -5.54 pct during the past four quarters. Stellar Biotechnologies Inc (SBOT) traded at $3.36 + 0.25 (8.04 pct) on 3,800 total ...and more »
05/17/16 03:33 PMSTELLAR BIOTECHNOLOGIES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial -
05/16/16 09:30 AMSBOT: JV Consummated, Neovacs' Lupus Candidate Closer to Commercialization -
05/12/16 10:32 AMStellar Biotechnologies, Inc. :SBOT-US: Earnings Analysis: Q2, 2016 By the Numbers -
05/12/16 09:23 AMNeovacs : Néovacs et Stellar Biotechnologies signent leur accord définitif pour créer Neostell SAS - Zonebourse.com - Neovacs : Néovacs et Stellar Biotechnologies signent leur accord définitif pour créer Neostell SASZonebourse.com... Stellar Biotechnologies Inc. ("Stellar") (Nasdaq: SBOT), qui détermine la création de la société de production Neostell SAS sous forme d'une joint-venture, basée en région parisienne, détenue à 70% par Néovacs et 30% par Stellar Biotechnologies.and more »
05/12/16 09:23 AMStellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines ... - Marketwired (press release) - Stellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines ...Marketwired (press release)PORT HUENEME, CA and PARIS, FRANCE and BOSTON, MA--(Marketwired - May 11, 2016) - Stellar Biotechnologies, Inc. ("Stellar") ( NASDAQ : SBOT) and Neovacs S.A. ("Neovacs") (Alternext Paris: ALNEV) today announced their entry into a joint venture ...
05/12/16 09:23 AMNeovacs and Stellar Biotechnologies sign a joint venture agreement to create Neostell SAS - Yahoo Finance UK - Neovacs and Stellar Biotechnologies sign a joint venture agreement to create Neostell SASYahoo Finance UK... company Stellar Biotechnologies Inc. ("Stellar") (Nasdaq: SBOT), to determine the creation of the production company Neostell SAS under a form of a joint venture, based in the Paris area and owned 70% by Neovacs and 30% by Stellar Biotechnologies.Stellar Biotechnologies Shares Rise More Than 2% on JV With Neovacs to Make Conjugated Therapeutic Vaccines ...Sonoran Weekly ReviewStellar Biotechnologies' (SBOT) CEO Frank Oakes on Q2 2016 Results - Earnings Call TranscriptSeeking AlphaStellar Biotechnologies Inc's Trend Up, Especially After Today's Strong SessionFranklin Independentall 5 news articles »
05/12/16 04:17 AMNeovacs and Stellar Biotechnologies sign joint venture agreement to create Neostell SAS - [at noodls] - Paris and Boston, May 12, 2016 - Neovacs (Alternext Paris: ALNEV)a leader in active immunotherapy for the treatment of autoimmune diseases, today announced that the Company has finalized the terms of its ...
05/11/16 09:29 AMStellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines ... - Digital Journal - Stellar Biotechnologies and Neovacs Sign Joint Venture Agreement to Manufacture Conjugated Therapeutic Vaccines ...Digital JournalPORT HUENEME, CA and PARIS, FRANCE and BOSTON, MA--(Marketwired - May 11, 2016) - Stellar Biotechnologies, Inc. ("Stellar") ( NASDAQ : SBOT ) and Neovacs S.A. ("Neovacs") (Alternext Paris: ALNEV) today announced their entry into a joint venture ...

Social

About Stellar Biotechnologies

Stellar Biotechnologies, Inc. (Stellar) is a biotechnology company. The Company is engaged in the aquaculture, research and development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH) protein. KLH is a high molecular weight and immune-stimulating protein. It operates under the brand name Stellar KLH. Its products include Stellar KLH protein in various grades, formulations and configurations for both clinical and preclinical applications. Stellar KLH can be used for therapeutic vaccine conjugation, as a carrier molecule in immunotherapies and as an immune stimulant in immunotoxicology applications. KLH can be used as an active pharmaceutical ingredient and combined with a disease-targeting agent to create immunotherapies targeting cancer, immune disorders, Alzheimer's disease and inflammatory diseases, or it can be used as a finished, injectable product in the immunodiagnostic market for measuring immune response in patients and research settings.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SBOT
  • CUSIP:
Key Metrics:
  • Previous Close: $3.23
  • 50 Day Moving Average: $3.3591
  • 200 Day Moving Average: $4.5427
  • P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $27.29M
  • Beta: 0.62
  • Current Year EPS Consensus Estimate: $-0.64 EPS
  • Next Year EPS Consensus Estimate: $-0.72 EPS
Additional Links:
Stellar Biotechnologies (NASDAQ:SBOT) Chart for Sunday, July, 24, 2016